Gallant Reports Positive Pilot Data for Feline Osteoarthritis Stem Cell Therapy; Receives FDA Eligibility for Expanded Conditional Approval Pathway

Randomized, placebo-controlled study shows over 76% of treated cats demonstrated improved quality of life SAN DIEGO, April 15, 2026 /PRNewswire/ -- Gallant, an animal health biotechnology company ...
BMJ

Severe upper airway obstruction caused by ulcerative laryngitis

Paediatric Intensive Care Unit, Institute of Child Health, Red Cross War Memorial Children's Hospital, Klipfontein Road, Cape Town, 7700, South Africa AIMS To present our experience of severe upper ...
dvm360

Ready-to-use feline OA stem cell therapy gains entry to FDA’s faster conditional approval pathway

A stem cell therapy with potential disease-modifying effects for feline osteoarthritis (OA) is underway.